Biosurgery Market Challenges, Size, Growth, Key Vendors, Drivers till 2030
Biosurgery products are used in numerous surgical procedures
to minimize intra- and post-operative complications. The increasing geriatric
population, a growing number of surgical procedures, rising occurrences of
trauma and sports-related injuries are the major factors driving the growth of
the global biosurgery market. Biosurgery
Market is expected to grow during the forecast period (2018–2023) at a CAGR
7.0%.
Additionally, increasing R&D spending and aggressive
strategies adopted by the top players, such as new product launches, are
contributing to the growth of the biosurgery market. For instance, in March
2015, Kuros Biosurgery announced the grant of a US patent for its synthetic
hydrogel technology which is a combination of bioactive and biomaterial
products such as sealants and orthobiologics.The high costs associated with
surgeries, stringent regulatory environment for product approval, and
increasing popularity of minimally invasive surgeries are likely to hinder
market growth during the forecast period. biosurgery
companies will face certain challenges during the forecast period 2020 to
2027.
Segmentation
The global biosurgery market has been segmented on the basis
of product, source, and application.
On the basis of product, the market has been classified as
bone graft substitutes, hemostatic agents, soft-tissue attachments, surgical sealants
and adhesives, adhesion barriers, and staple-line reinforcement agents. The
bone-graft substitutes segment has been further divided into demineralized bone
matrix, synthetic bone grafts, bone morphogenetic proteins, and other
bone-graft substitutes. The hemostatic agents segment has been further divided
into thrombin-based hemostatic agents, oxidized regenerated cellulose-based
hemostatic agents, and combination hemostatic agents. The soft-tissue
attachments segment has been classified as synthetic meshes and biological
meshes. The surgical sealants and adhesives segment has been divided into
natural and synthetic sealants and adhesives. The natural sealants sub-segment
has been segmented into fibrin sealants, collagen-based sealants, gelatin-based
sealants, albumin-based sealants, and other natural sealants. The synthetic
sealants segment has been divided into peg hydrogels, cyanoacrylate-based
sealants and adhesives, urethane-based sealants and adhesives, and others.
Furthermore, the adhesion barriers segment has been sub-segmented into
synthetic and natural adhesion barriers. The synthetic adhesion barriers
segment includes hyaluronic acid-based, peg-based, and ther synthetic barriers.
The natural adhesion barriers segment includes collagen- and fibrin-based
adhesion barriers.
The market, by source, has been segmented into biological
and natural products. On basis of application, the market has been divided into
neurological surgery, general surgery, cardiovascular surgery, orthopedic
surgery, thoracic surgery, gynecology surgery, reconstructive surgery, and
urology surgery.
Key Players
Some of the key players in the global biosurgery market are
Baxter International, Inc., B. Braun
Melsungen AG, C.R. Bard, Johnson & Johnson, Medtronic, PLC., MAQUET Holding
B.V. & Co. Kg. (Getinge Group), Cohera Medical Inc., Integra Lifesciences
Holdings Corporation, Commonwealth Serum Laboratories (CSL), Hemostasis, LLC,
Sanofi, Pfizer Inc., Stryker Corporation, Cryolife, Inc., and Kuros Biosciences
Ltd.
Regional Analysis
The market in the Americas is expected to dominate the
global biosurgery market during the forecast period owing to the increasing
prevalence of chronic diseases along with the growing geriatric population,
rising occurrences of injuries, and well-established healthcare sector in the
region. The European market is expected to be the second-largest due to
government funding and support of the healthcare sector, coupled with
increasing research and development. Moreover, the market in Asia-Pacific is anticipated
to be the fastest-growing during the forecast period owing to technological
development, an increasing number of advanced surgeries in emerging economies,
and favorable government initiatives for healthcare facilities. The market in
the Middle East & Africa is likely to account for the smallest share of the
global biosurgery market. The market growth in this region can be attributed to
increasing healthcare expenditure and low manufacturing costs of
pharmaceuticals.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to
unravel the complexity of various industries through our Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York, New York 10013,
United States of America
+1 646 845 9312
Comments
Post a Comment